FDA Chides Glaxo for Cancer-Drug Ad - WSJ.com
Links shared publicly online about this topic.
- 1,235total visits
FDA Chides Glaxo for Cancer-Drug Ad - WSJ.com
The FDA on Friday said an advertisement for a Glaxo cancer drug and a Web site for a bladder treatment the company co-promotes were false or misleading. The agency also took issue with a consumer email from Novartis about its pain gel Voltaren.
View full resource at online.wsj.com
Tags: Osteoarthritis Medication, Rheumatoid Arthritis Medication, Urinary System, Drug, FDA, NSAIDs, Voltaren, Novartis
Most Recently Shared on April 17, 2010 at 3:41 am By:
FDA Chides Glaxo for Cancer-Drug Ad http://on.wsj.com/auoDPL
GSK - Arzerra: FDA Chides Glaxo for Cancer-Drug Ad - Jack's posterous
pharmagossip.posterous.com — “GSK - Arzerra: FDA Chides Glaxo for Cancer-Drug Ad - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on April 17, 2010 at 5:23 am By:
Jack Friday - PharmaGossip Health Blog
GSK - Arzerra: FDA Chides Glaxo for Cancer-Drug Ad http://post.ly/b3Ka
Advertisement
